Resumen
Se realiza una revisión actualizada sobre las epilepsias debidas a alteraciones de los diferentes canales iónicos. Se hace énfasis en su presentación clínica, genotipificación y fisiopatología. Se aborda tentativamente una aproximación al tratamiento farmacológico.
Citas
Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 1952; 117: 500-544.
Katz B. The release of neuronal transmitter substances. Liverpool: Liverpool University Press.
Neher E, Sakmann B. Single channel current recorded from membrane of denervated frog muscle fibers. Nature 1976; 260: 799-802.
JL Herranz. Canalopatías: un nuevo concepto en la etiología de las epilepsias. Bol Pediatr 2002; 42: 20-30.
Koehling R. Voltaje gated Sodium Channels in Epilepsy. Epilepsia 2002; 43: 1278-1295.
Sanguinetti MC, Spector PS. Potassium channelo- pathies. Neuropharmacology 1997; 36: 755-762.
Ackerman MJ, Clapham DE. Ion Channels basic science and clinical disease. N Engl J Med 1997; 336: 1575-1586.
Zuberi SM, Hanna MG. Ion channels and neurology. Arch Dis Child 2001; 84: 277-280.
Barchi RL. Ion channel mutations affecting muscle and brain. Curr Opin Neurol 1998; 11: 461-468.
Grippo J, Grippo T. Canalopatías en neurología. Rev Neurol 2001; 33: 643-647.
Bennatar M. Neurological potassium channelo- pathies. Q J Med 2000; 93: 787-797.
Velez MM, Carrizosa J, Cornejo W. Parálisis periódica hipocalémica familiar (PPHF): reporte de un caso y revisión del tema. IATREIA 2002; 2: 114-120.
Carrera P, Stenirri S, Ferrari M. Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull 2001; 56: 239-241.
Greenberg DA. Calcium channels in neurological disease. Ann Neurol 1997; 42: 275-282.
Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003; 16: 171-176.
Campos-Castelló J, Canción de López M, Briceño-Cuadros S, Villalobos-Valderrey I. Canalopatías epilépticas. Rev Neurol 2002; 34: 145-149.
Scheffer I, Berkovic SF. Generalized epilepsy with febrile seizures plus: A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-490.
Harkin LA, Bowser DN, Dibbens LM, Singh R, Phillips F, Wallace RH, et al. Truncation of the GABA A Receptor gamma2 Subunit in a Family with Generalized Epilepsy with Febrile Seizures Plus. Am J Hum Genet 2002; 70: 530-536.
Gérard F, Pereira S, Robaglia-Schlupp A, Genton P, Szepetowski P. Clinical and Genetic Analysis of a New Multigenerational Pedigree with GEFS+ (Generalized Epilepsy with Febrile Seizures Plus). Epilepsia 2002; 43: 581-586.
MacDonald BT, Meisler MH, Escayg A, Heils A, Haug K, Sander T. A Novel SCN1A Mutation Associated with Generalized Epilepsy with Febrile Seizures Plus and Prevalence of Variants in Patients with Epilepsy. Am J Hum Genet 2001; 68: 866- 874.
Barnett S, Richards M, Gardner A, Wallace RH, Dibbens L, Kremmidiotis G, et al. Neuronal Sodium Channel alpha 1 Subunit Mutations in Generalized Epilepsy with Febrile Seizures Plus. Am J Hum Genet 2001; 68: 859-866.
Baulac S, Gourfinkel-An I, Picard F, Rosemberg- Bourgin M, Prud’homme JF, Baulac M, et al. A Second locus for Familial Generalized Epilepsy with Febrile Seizures Plus maps to Chromosome 2q21-q33. Am J Hum Genet 1999; 65: 1078-1085.
Moulard B, Guipponi M, Chaigne D, Mouthon D, Buresi C, Malafosse A. Identification of a New Locus for Generalized Epilepsy with Febrile Seizures Plus (GEFS+) on Chromosome 2q24-q33. Am J Hum Genet 1999; 65: 1396-1400.
Lopes-Cendes I, Scheffer E, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. A New Locus for Generalized Epilepsy with Febrile Seizures Plus. Am J Hum Genet 2000; 66:698-701.
Wallace RH, Scheffer I, Parasivam G, Barnett S, Wallace GB, Sutherland GR, et al. Generalized epilepsy with febrile seizures plus: Mutation of the sodium channel subunit SCN1B. Neurology 2002; 58: 1426-1429.
Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized Epilepsy with Febrile Seizures Plus: A Common Childhood Onset Genetic Epilepsy Syndrome. Ann Neurol 1999; 45: 75-81.
Alzate DC, Carrizosa J, Bedoya G. Mutaciones de los canales neuronales de sodio y cloro asociadas a epilepsia generalizada con convulsiones febriles plus. IATREIA 2004; 17: 115-123.
Pineda-Trujillo N, Carrizosa J, Cornejo W, Arias W, Franco C, Cabrera D. et al. A novel SCN1A mutation associated with severe GEFS+ in a large South American pedigree. Seizure 2005;14:123-128.
Kananura C, Haug K, Sander T, Runge U, Gu W, Hallmann K, et al. A Splice Site Mutation in GABRG2 Associated With Childhood Absence Epilepsy and Febrile Convulsions. Arch Neurol 2002; 59: 1137-1141.
Wallace RH, Marini C, Petrou S. Mutant GABA A receptor gamma 2 subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001;28:49-52.
Castaldo P, del Giudice EM, Coppola G, Bellini G, Galazo F, Soldovieri MV, et al. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J Neurosci 2002;22: 1-6.
Rogawski MA. KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci 2000; 23: 393-398.
Dedek K, Kunath B, Kananura C, Reiner U, Jentsch TJ, Steinlein OK. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci USA 2001; 98: 12272-12277.
Leppert M, McMahon WM, Quattlebaum TG, Stauffer D, O’Connell P, Nakamura Y, et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989; 337: 647-648.
Lewis TB, Leach RJ, Ward K, Oconnell P, Ryan SG. Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 1993; 53: 670-676.
Singh NA, Charlier C, Stauffer D, DuPont DR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998; 18: 25-29.
Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De Novo Mutations in the Sodium Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy. Am J Hum Genet 2001; 68: 1327-1332.
Sugawara T, Mazaki-Miyazaki E, Fufushima K, Shimomura J, Fujiwara T, Hamano S, et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002, 58: 1122-1124.
Ceulemans B, Claes L, Lagde L, Del Farero J. Severe myoclonic epilepsy of infancy is caused by de novo mutation in the SCN1A gene. Eur J Paediatric Neurol 2001; 5: 163-164.
Bertrand D, Picard F, Le Hellard S. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia
; 43: 112-122.
Scheffer IE, Bhatia KP, Lopes Cendes I, Fish DR, Marsden CD, Andermann E, et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 1995; 118: 61-73.
Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillipps HA, Sutherland GR, et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11:201-203.
Mizuno K, Okada M, Murakami T, Kamata A, Zhu G, Kawata Y, et al. Effects os carbamazepine on acetylcholine release and metabolism. Epilepsy Res 2000; 40: 187-195.
Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire JM, et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002; 31: 184-189.
Delgado Escueta AV, Medina MT, Serratosa JM. Mapping and positional cloning of common idiopathic generalized epilepsies: juvenile myoclonus epilepsy and childhood absence epilepsy. En: Delgado Escueta AV, Wilson WA, Olsen RW, Porter RJ (Eds). Jasper’s basic mechanisms of the epilepsies. Advances in Neurology. Vol 79, 3ra ed. Philadelphia: Lippincott-Williams&willkins;1999; 499-374.
Elmslie FV, Rees M, Williamson MP, Kerr M. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15p. Hum Mol Genet 1997; 6: 1329- 1334.
Heron SE, Crossland KM, Andermann E. Sodium channel defects in benign familial neonatal infantile seizures. Lancet 2002; 360:851-852.
Kaminska A, Ickowicz A, Plouin P, Bru MF, Dellatollas G, Dulac O. Delinration of cryptogenic Lennoz Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 1999; 36:15 - 29.
Oguni H, Fukuyama Y, Imaizumi Y, Uehara T. Video EEG análisis of drop seizures in myoclonic astatic epilepsy of early childhood Doose syndrome. Epilepsia 1992; 33: 805-813.
Rogers SW, Andrews PI, Gahring LC. Autoantibodies to glutamate receptor GluR3 in Rasmussen´s encephalitis. Science 1994; 265: 648-651.
Wagstaff J, Knoll JH, Fleming J, Kirkness EF, Martin-Gallardo A, Greenberg F, et al. Localization of the gene encoding the GABA (A) receptor beta 3 subunit to the Angelman/Prader/Willy region of human chromosome 15. Am J Hum Genet 1991; 49: 330-337.
Yamakawa K, MitchellS, Hubert R, Chen XN, Colbern S, Hu YK et al. Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum Mol Genet 1995;4: 709-716.
Evans WE, McLeod H. Pharmacogenomics- Drug Disposition, Drug Targets, and Side Effects. N Engl J Med 2003; 348: 538-549.
Weinshilbourn R. Inheritance and Drug Response. N Engl J Med 2003; 348: 529-537.
Jain KK. Modulators of ion channels and transporters: Current status and future potential. Basel: Jain Pharma Biotech Publications 2001.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.